Financial Metrics

CELG-RI BRISTOL MYERS SQUIBB CO

Range: 2016-01-01 to 2026-04-29

Export Quarterly CSV Export Annual CSV

Chart Range:

% Change:

Annual View:

Financial Statements

Grouped by statement

Income Statement

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.71	—	USD/shares	10-Q	2017-04-27
Quarterly	2016-06-30	0.69	-2.8%	USD/shares	10-Q	2017-07-27
Quarterly	2016-09-30	0.72	+4.3%	USD/shares	10-Q	2017-10-26
Quarterly	2017-03-31	0.94	+30.6%	USD/shares	10-Q	2018-04-26
Quarterly	2017-06-30	0.56	-40.4%	USD/shares	10-Q	2018-07-26
Quarterly	2017-09-30	0.51	-8.9%	USD/shares	10-Q	2018-10-25
Quarterly	2018-03-31	0.91	+78.4%	USD/shares	10-Q	2019-04-25
Quarterly	2018-06-30	0.23	-74.7%	USD/shares	10-Q	2019-07-25
Quarterly	2018-09-30	1.16	+404.3%	USD/shares	10-Q	2019-10-31
Quarterly	2019-03-31	1.04	-10.3%	USD/shares	10-Q	2020-05-07
Quarterly	2019-06-30	0.87	-16.3%	USD/shares	10-Q	2020-08-06
Quarterly	2019-09-30	0.83	-4.6%	USD/shares	10-Q	2020-11-05
Quarterly	2020-03-31	-0.34	-141.0%	USD/shares	10-Q	2021-04-29
Quarterly	2020-06-30	-0.04	+88.2%	USD/shares	10-Q	2021-07-28
Quarterly	2020-09-30	0.82	+2150.0%	USD/shares	10-Q	2021-10-27
Quarterly	2021-03-31	0.89	+8.5%	USD/shares	10-Q	2022-04-29
Quarterly	2021-06-30	0.47	-47.2%	USD/shares	10-Q	2022-07-27
Quarterly	2021-09-30	0.69	+46.8%	USD/shares	10-Q	2022-10-26
Quarterly	2022-03-31	0.59	-14.5%	USD/shares	10-Q	2023-04-27
Quarterly	2022-06-30	0.66	+11.9%	USD/shares	10-Q	2023-07-27
Quarterly	2022-09-30	0.75	+13.6%	USD/shares	10-Q	2023-10-26
Quarterly	2023-03-31	1.07	+42.7%	USD/shares	10-Q	2024-04-25
Quarterly	2023-06-30	0.99	-7.5%	USD/shares	10-Q	2024-07-26
Quarterly	2023-09-30	0.93	-6.1%	USD/shares	10-Q	2024-10-31
Quarterly	2024-03-31	-5.89	-733.3%	USD/shares	10-Q	2025-04-24
Quarterly	2024-06-30	0.83	+114.1%	USD/shares	10-Q	2025-07-31
Quarterly	2024-09-30	0.6	-27.7%	USD/shares	10-Q	2025-10-30
Quarterly	2025-03-31	1.2	+100.0%	USD/shares	10-Q	2025-04-24
Quarterly	2025-06-30	0.64	-46.7%	USD/shares	10-Q	2025-07-31
Quarterly	2025-09-30	1.08	+68.8%	USD/shares	10-Q	2025-10-30
Annual	2016-12-31	2.65	—	USD/shares	10-K	2019-02-25
Annual	2017-12-31	0.61	-77.0%	USD/shares	10-K	2020-02-24
Annual	2018-12-31	3.01	+393.4%	USD/shares	10-K	2021-02-10
Annual	2019-12-31	2.01	-33.2%	USD/shares	10-K	2022-02-09
Annual	2020-12-31	-3.99	-298.5%	USD/shares	10-K	2023-02-14
Annual	2021-12-31	3.12	+178.2%	USD/shares	10-K	2024-02-13
Annual	2022-12-31	2.95	-5.4%	USD/shares	10-K	2025-02-12
Annual	2023-12-31	3.86	+30.8%	USD/shares	10-K	2026-02-11
Annual	2024-12-31	-4.41	-214.2%	USD/shares	10-K	2026-02-11
Annual	2025-12-31	3.46	+178.5%	USD/shares	10-K	2026-02-11

Balance Sheet

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	6593000000.0	—	USD	10-Q	2016-04-28
Quarterly	2016-06-30	6581000000.0	-0.2%	USD	10-Q	2016-07-28
Quarterly	2016-09-30	5836000000.0	-11.3%	USD	10-Q	2016-10-27
Quarterly	2016-12-31	5716000000.0	-2.1%	USD	10-Q	2017-10-26
Quarterly	2017-03-31	7237000000.0	+26.6%	USD	10-Q	2017-04-27
Quarterly	2017-06-30	6911000000.0	-4.5%	USD	10-Q	2017-07-27
Quarterly	2017-09-30	6982000000.0	+1.0%	USD	10-Q	2017-10-26
Quarterly	2017-12-31	6975000000.0	-0.1%	USD	10-Q	2018-10-25
Quarterly	2018-03-31	5775000000.0	-17.2%	USD	10-Q	2018-04-26
Quarterly	2018-06-30	5671000000.0	-1.8%	USD	10-Q	2018-07-26
Quarterly	2018-09-30	5687000000.0	+0.3%	USD	10-Q	2018-10-25
Quarterly	2018-12-31	6895000000.0	+21.2%	USD	10-Q	2019-10-31
Quarterly	2019-03-31	5635000000.0	-18.3%	USD	10-Q	2019-04-25
Quarterly	2019-06-30	24433000000.0	+333.6%	USD	10-Q	2019-07-25
Quarterly	2019-09-30	24390000000.0	-0.2%	USD	10-Q	2019-10-31
Quarterly	2019-12-31	46150000000.0	+89.2%	USD	10-Q	2020-11-05
Quarterly	2020-03-31	46105000000.0	-0.1%	USD	10-Q	2020-05-07
Quarterly	2020-06-30	46106000000.0	+0.0%	USD	10-Q	2020-08-06
Quarterly	2020-09-30	44614000000.0	-3.2%	USD	10-Q	2020-11-05
Quarterly	2020-12-31	50336000000.0	+12.8%	USD	10-Q	2021-10-27
Quarterly	2021-03-31	46005000000.0	-8.6%	USD	10-Q	2021-04-29
Quarterly	2021-06-30	45000000000.0	-2.2%	USD	10-Q	2021-07-28
Quarterly	2021-09-30	44446000000.0	-1.2%	USD	10-Q	2021-10-27
Quarterly	2021-12-31	44369000000.0	-0.2%	USD	10-Q	2022-10-26
Quarterly	2022-03-31	44747000000.0	+0.9%	USD	10-Q	2022-04-29
Quarterly	2022-06-30	41753000000.0	-6.7%	USD	10-Q	2022-07-27
Quarterly	2022-09-30	38869000000.0	-6.9%	USD	10-Q	2022-10-26
Quarterly	2022-12-31	38953000000.0	+0.2%	USD	10-Q	2023-10-26
Quarterly	2023-03-31	37332000000.0	-4.2%	USD	10-Q	2023-04-27
Quarterly	2023-06-30	37070000000.0	-0.7%	USD	10-Q	2023-07-27
Quarterly	2023-09-30	37010000000.0	-0.2%	USD	10-Q	2023-10-26
Quarterly	2023-12-31	39526000000.0	+6.8%	USD	10-Q	2024-10-31
Quarterly	2024-03-31	52360000000.0	+32.5%	USD	10-Q	2024-04-25
Quarterly	2024-06-30	51950000000.0	-0.8%	USD	10-Q	2024-07-26
Quarterly	2024-09-30	49547000000.0	-4.6%	USD	10-Q	2024-10-31
Quarterly	2024-12-31	49431000000.0	-0.2%	USD	10-Q	2025-10-30
Quarterly	2025-03-31	49506000000.0	+0.2%	USD	10-Q	2025-04-24
Quarterly	2025-06-30	48945000000.0	-1.1%	USD	10-Q	2025-07-31
Quarterly	2025-09-30	48717000000.0	-0.5%	USD	10-Q	2025-10-30
Annual	2016-12-31	5716000000.0	—	USD	10-K	2018-02-13
Annual	2017-12-31	6975000000.0	+22.0%	USD	10-K	2019-02-25
Annual	2018-12-31	6895000000.0	-1.1%	USD	10-K	2020-02-24
Annual	2019-12-31	46150000000.0	+569.3%	USD	10-K	2021-02-10
Annual	2020-12-31	50336000000.0	+9.1%	USD	10-K	2022-02-09
Annual	2021-12-31	44369000000.0	-11.9%	USD	10-K	2023-02-14
Annual	2022-12-31	38953000000.0	-12.2%	USD	10-K	2024-02-13
Annual	2023-12-31	39526000000.0	+1.5%	USD	10-K	2025-02-12
Annual	2024-12-31	49431000000.0	+25.1%	USD	10-K	2026-02-11
Annual	2025-12-31	44827000000.0	-9.3%	USD	10-K	2026-02-11

Cash Flow

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	242000000.0	—	USD	10-Q	2017-04-27
Quarterly	2016-06-30	503000000.0	+107.9%	USD	10-Q	2017-07-27
Quarterly	2016-09-30	844000000.0	+67.8%	USD	10-Q	2017-10-26
Quarterly	2017-03-31	291000000.0	-65.5%	USD	10-Q	2018-04-26
Quarterly	2017-06-30	539000000.0	+85.2%	USD	10-Q	2018-07-26
Quarterly	2017-09-30	801000000.0	+48.6%	USD	10-Q	2018-10-25
Quarterly	2018-03-31	239000000.0	-70.2%	USD	10-Q	2019-04-25
Quarterly	2018-06-30	437000000.0	+82.8%	USD	10-Q	2019-07-25
Quarterly	2018-09-30	661000000.0	+51.3%	USD	10-Q	2019-10-31
Quarterly	2019-03-31	204000000.0	-69.1%	USD	10-Q	2020-05-07
Quarterly	2019-06-30	395000000.0	+93.6%	USD	10-Q	2020-08-06
Quarterly	2019-09-30	585000000.0	+48.1%	USD	10-Q	2020-11-05
Quarterly	2020-03-31	186000000.0	-68.2%	USD	10-Q	2021-04-29
Quarterly	2020-06-30	317000000.0	+70.4%	USD	10-Q	2021-07-28
Quarterly	2020-09-30	470000000.0	+48.3%	USD	10-Q	2021-10-27
Quarterly	2021-03-31	173000000.0	-63.2%	USD	10-Q	2022-04-29
Quarterly	2021-06-30	383000000.0	+121.4%	USD	10-Q	2022-07-27
Quarterly	2021-09-30	653000000.0	+70.5%	USD	10-Q	2022-10-26
Quarterly	2022-03-31	253000000.0	-61.3%	USD	10-Q	2023-04-27
Quarterly	2022-06-30	525000000.0	+107.5%	USD	10-Q	2023-07-27
Quarterly	2022-09-30	772000000.0	+47.0%	USD	10-Q	2023-10-26
Quarterly	2023-03-31	278000000.0	-64.0%	USD	10-Q	2024-04-25
Quarterly	2023-06-30	537000000.0	+93.2%	USD	10-Q	2024-07-26
Quarterly	2023-09-30	879000000.0	+63.7%	USD	10-Q	2024-10-31
Quarterly	2024-03-31	284000000.0	-67.7%	USD	10-Q	2025-04-24
Quarterly	2024-06-30	546000000.0	+92.3%	USD	10-Q	2025-07-31
Quarterly	2024-09-30	870000000.0	+59.3%	USD	10-Q	2025-10-30
Quarterly	2025-03-31	260000000.0	-70.1%	USD	10-Q	2025-04-24
Quarterly	2025-06-30	621000000.0	+138.8%	USD	10-Q	2025-07-31
Quarterly	2025-09-30	941000000.0	+51.5%	USD	10-Q	2025-10-30
Annual	2016-12-31	1215000000.0	—	USD	10-K	2019-02-25
Annual	2017-12-31	1055000000.0	-13.2%	USD	10-K	2020-02-24
Annual	2018-12-31	951000000.0	-9.9%	USD	10-K	2021-02-10
Annual	2019-12-31	836000000.0	-12.1%	USD	10-K	2022-02-09
Annual	2020-12-31	753000000.0	-9.9%	USD	10-K	2023-02-14
Annual	2021-12-31	973000000.0	+29.2%	USD	10-K	2024-02-13
Annual	2022-12-31	1118000000.0	+14.9%	USD	10-K	2025-02-12
Annual	2023-12-31	1209000000.0	+8.1%	USD	10-K	2026-02-11
Annual	2024-12-31	1248000000.0	+3.2%	USD	10-K	2026-02-11
Annual	2025-12-31	1311000000.0	+5.0%	USD	10-K	2026-02-11

Share Data

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	1680000000.0	—	shares	10-Q	2017-04-27
Quarterly	2016-06-30	1679000000.0	-0.1%	shares	10-Q	2017-07-27
Quarterly	2016-09-30	1679000000.0	+0.0%	shares	10-Q	2017-10-26
Quarterly	2017-03-31	1671000000.0	-0.5%	shares	10-Q	2018-04-26
Quarterly	2017-06-30	1650000000.0	-1.3%	shares	10-Q	2018-07-26
Quarterly	2017-09-30	1645000000.0	-0.3%	shares	10-Q	2018-10-25
Quarterly	2018-03-31	1640000000.0	-0.3%	shares	10-Q	2019-04-25
Quarterly	2018-06-30	1636000000.0	-0.2%	shares	10-Q	2019-07-25
Quarterly	2018-09-30	1636000000.0	+0.0%	shares	10-Q	2019-10-31
Quarterly	2019-03-31	1637000000.0	+0.1%	shares	10-Q	2020-05-07
Quarterly	2019-06-30	1637000000.0	+0.0%	shares	10-Q	2020-08-06
Quarterly	2019-09-30	1634000000.0	-0.2%	shares	10-Q	2020-11-05
Quarterly	2020-03-31	2258000000.0	+38.2%	shares	10-Q	2021-04-29
Quarterly	2020-06-30	2263000000.0	+0.2%	shares	10-Q	2021-07-28
Quarterly	2020-09-30	2290000000.0	+1.2%	shares	10-Q	2021-10-27
Quarterly	2021-03-31	2265000000.0	-1.1%	shares	10-Q	2022-04-29
Quarterly	2021-06-30	2252000000.0	-0.6%	shares	10-Q	2022-07-27
Quarterly	2021-09-30	2243000000.0	-0.4%	shares	10-Q	2022-10-26
Quarterly	2022-03-31	2164000000.0	-3.5%	shares	10-Q	2023-04-27
Quarterly	2022-06-30	2149000000.0	-0.7%	shares	10-Q	2023-07-27
Quarterly	2022-09-30	2148000000.0	-0.0%	shares	10-Q	2023-10-26
Quarterly	2023-03-31	2113000000.0	-1.6%	shares	10-Q	2024-04-25
Quarterly	2023-06-30	2102000000.0	-0.5%	shares	10-Q	2024-07-26
Quarterly	2023-09-30	2064000000.0	-1.8%	shares	10-Q	2024-10-31
Quarterly	2024-03-31	2023000000.0	-2.0%	shares	10-Q	2025-04-24
Quarterly	2024-06-30	2029000000.0	+0.3%	shares	10-Q	2025-07-31
Quarterly	2024-09-30	2031000000.0	+0.1%	shares	10-Q	2025-10-30
Quarterly	2025-03-31	2040000000.0	+0.4%	shares	10-Q	2025-04-24
Quarterly	2025-06-30	2038000000.0	-0.1%	shares	10-Q	2025-07-31
Quarterly	2025-09-30	2039000000.0	+0.0%	shares	10-Q	2025-10-30
Annual	2016-12-31	1680000000.0	—	shares	10-K	2019-02-25
Annual	2017-12-31	1652000000.0	-1.7%	shares	10-K	2020-02-24
Annual	2018-12-31	1637000000.0	-0.9%	shares	10-K	2021-02-10
Annual	2019-12-31	1712000000.0	+4.6%	shares	10-K	2022-02-09
Annual	2020-12-31	2258000000.0	+31.9%	shares	10-K	2023-02-14
Annual	2021-12-31	2245000000.0	-0.6%	shares	10-K	2024-02-13
Annual	2022-12-31	2146000000.0	-4.4%	shares	10-K	2025-02-12
Annual	2023-12-31	2078000000.0	-3.2%	shares	10-K	2026-02-11
Annual	2024-12-31	2027000000.0	-2.5%	shares	10-K	2026-02-11
Annual	2025-12-31	2039000000.0	+0.6%	shares	10-K	2026-02-11

Credit and Bond Coverage

Company-level

Long-Term Debt (latest annual)

44,827,000,000

Total Liabilities (latest annual)

71,533,000,000

Current Liabilities (latest annual)

23,417,000,000

Metrics

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.0829	—	ratio	10-Q	2017-04-27
Quarterly	2016-06-30	0.0788	-4.9%	ratio	10-Q	2017-07-27
Quarterly	2016-09-30	0.0770	-2.3%	ratio	10-Q	2017-10-26
Quarterly	2017-03-31	0.1050	+36.4%	ratio	10-Q	2018-04-26
Quarterly	2017-06-30	0.0622	-40.7%	ratio	10-Q	2018-07-26
Quarterly	2017-09-30	0.0574	-7.7%	ratio	10-Q	2018-10-25
Quarterly	2018-03-31	0.1158	+101.8%	ratio	10-Q	2019-04-25
Quarterly	2018-06-30	0.0308	-73.4%	ratio	10-Q	2019-07-25
Quarterly	2018-09-30	0.1391	+352.0%	ratio	10-Q	2019-10-31
Quarterly	2019-03-31	0.1120	-19.5%	ratio	10-Q	2020-05-07
Quarterly	2019-06-30	0.0891	-20.4%	ratio	10-Q	2020-08-06
Quarterly	2019-09-30	0.0769	-13.6%	ratio	10-Q	2020-11-05
Quarterly	2020-03-31	-0.0153	-119.9%	ratio	10-Q	2021-04-29
Quarterly	2020-06-30	-0.0016	+89.4%	ratio	10-Q	2021-07-28
Quarterly	2020-09-30	0.0374	+2397.5%	ratio	10-Q	2021-10-27
Quarterly	2021-03-31	0.0539	+44.1%	ratio	10-Q	2022-04-29
Quarterly	2021-06-30	0.0288	-46.6%	ratio	10-Q	2022-07-27
Quarterly	2021-09-30	0.0416	+44.7%	ratio	10-Q	2022-10-26
Quarterly	2022-03-31	0.0405	-2.6%	ratio	10-Q	2023-04-27
Quarterly	2022-06-30	0.0438	+7.9%	ratio	10-Q	2023-07-27
Quarterly	2022-09-30	0.0491	+12.3%	ratio	10-Q	2023-10-26
Quarterly	2023-03-31	0.0711	+44.7%	ratio	10-Q	2024-04-25
Quarterly	2023-06-30	0.0648	-8.8%	ratio	10-Q	2024-07-26
Quarterly	2023-09-30	0.0665	+2.6%	ratio	10-Q	2024-10-31
Quarterly	2024-03-31	-0.7196	-1181.3%	ratio	10-Q	2025-04-24
Quarterly	2024-06-30	0.0987	+113.7%	ratio	10-Q	2025-07-31
Quarterly	2024-09-30	0.0706	-28.4%	ratio	10-Q	2025-10-30
Quarterly	2025-03-31	0.1411	+99.8%	ratio	10-Q	2025-04-24
Quarterly	2025-06-30	0.0751	-46.8%	ratio	10-Q	2025-07-31
Quarterly	2025-09-30	0.1180	+57.2%	ratio	10-Q	2025-10-30
Annual	2016-12-31	0.2757	—	ratio	10-K	2019-02-25
Annual	2017-12-31	0.0823	-70.1%	ratio	10-K	2020-02-24
Annual	2018-12-31	0.3502	+325.5%	ratio	10-K	2021-02-10
Annual	2019-12-31	0.0669	-80.9%	ratio	10-K	2022-02-09
Annual	2020-12-31	-0.2374	-454.8%	ratio	10-K	2023-02-14
Annual	2021-12-31	0.1948	+182.0%	ratio	10-K	2024-02-13
Annual	2022-12-31	0.2039	+4.7%	ratio	10-K	2025-02-12
Annual	2023-12-31	0.2727	+33.7%	ratio	10-K	2026-02-11
Annual	2024-12-31	-0.5451	-299.9%	ratio	10-K	2026-02-11
Annual	2025-12-31	0.3812	+169.9%	ratio	10-K	2026-02-11

8-K Material Event Details

66 filings · 143 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

468 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value X-axis date:

All Transactions

Date	Insider	Title	Type	Security	Shares	Price	Total Value	Post-Tx Shares
2026-04-01	Shanahan Karin	EVP, Chief Supply Chain & Ops	Exercise / conversion M · derivative	Restricted Stock Units	3,307	$0.00	$0	0
2026-04-01	Shanahan Karin	EVP, Chief Supply Chain & Ops	Other disposed transaction F	Common Stock, $0.10 par value	1,692	$61.73	$104,447	25,888
2026-04-01	Shanahan Karin	EVP, Chief Supply Chain & Ops	Exercise / conversion M	Common Stock, $0.10 par value	3,307	$0.00	$0	27,580
2026-03-31	YALE PHYLLIS R	Dir	Equity grant / award A · derivative	Deferred Share Units	577	$60.65	$35,000	43,904
2026-03-10	Hickey Benjamin	President, RayzeBio Org.	Equity grant / award A · derivative	Performance Shares	17,143	$0.00	$0	17,143
2026-03-10	Hickey Benjamin	President, RayzeBio Org.	Equity grant / award A · derivative	Market Share Units	11,429	$0.00	$0	11,429
2026-02-27	Hickey Benjamin	President, RayzeBio Org.	Exercise / conversion M · derivative	Restricted Stock Units	3,286	$0.00	$0	3,286
2026-02-27	Hickey Benjamin	President, RayzeBio Org.	Other disposed transaction F	Common Stock, $0.10 par value	1,672	$62.37	$104,283	16,672
2026-02-27	Hickey Benjamin	President, RayzeBio Org.	Exercise / conversion M	Common Stock, $0.10 par value	3,286	$0.00	$0	18,344
2026-02-01	Meyers Gregory Scott	EVP, Chief Digital & Tech Off.	Exercise / conversion M · derivative	Restricted Stock Units	2,543	$0.00	$0	0
2026-02-01	Meyers Gregory Scott	EVP, Chief Digital & Tech Off.	Other disposed transaction F	Common Stock, $0.10 par value	833	$55.05	$45,857	21,428
2026-02-01	Meyers Gregory Scott	EVP, Chief Digital & Tech Off.	Exercise / conversion M	Common Stock, $0.10 par value	2,543	$0.00	$0	22,261
2025-12-31	YALE PHYLLIS R	Dir	Equity grant / award A · derivative	Deferred Share Units	649	$0.00	$0	38,892
2025-11-03	Lenkowsky Adam	EVP, Chief Commercial Officer	Equity grant / award A · derivative	Restricted Stock Units	22,568	$0.00	$0	22,568
2025-11-01	BOERNER CHRISTOPHER S.	Chief Executive Officer	Exercise / conversion M · derivative	Market Share Units	2,964	$0.00	$0	5,930
2025-11-01	BOERNER CHRISTOPHER S.	Chief Executive Officer	Other disposed transaction F	Common Stock, $0.10 par value	1,238	$46.07	$57,035	1,182
2025-11-01	BOERNER CHRISTOPHER S.	Chief Executive Officer	Other disposed transaction J	Common Stock, $0.10 par value	544	$0.00	$0	2,420
2025-11-01	BOERNER CHRISTOPHER S.	Chief Executive Officer	Exercise / conversion M	Common Stock, $0.10 par value	2,964	$0.00	$0	2,964
2025-10-02	Gallman Cari	EVP, General Counsel	Exercise / conversion M · derivative	Restricted Stock Units	4,558	$0.00	$0	4,559
2025-10-02	Gallman Cari	EVP, General Counsel	Other disposed transaction F	Common Stock, $0.10 par value	2,332	$45.73	$106,642	11,066
2025-10-02	Gallman Cari	EVP, General Counsel	Exercise / conversion M	Common Stock, $0.10 par value	4,558	$0.00	$0	13,398
2025-09-30	YALE PHYLLIS R	Dir	Equity grant / award A · derivative	Deferred Share Units	776	$0.00	$0	37,735
2025-09-02	Elkins David V	EVP, Chief Financial Officer	Open-market sell S	Common Stock, $0.10 par value	56,000	$47.33	$2,650,480	167,379
2025-09-01	Short Bartie Wendy	EVP, Corporate Affairs	Exercise / conversion M · derivative	Restricted Stock Units	1,235	$0.00	$0	1,236
2025-09-01	Short Bartie Wendy	EVP, Corporate Affairs	Other disposed transaction F	Common Stock, $0.10 par value	632	$47.18	$29,818	5,669
2025-09-01	Short Bartie Wendy	EVP, Corporate Affairs	Exercise / conversion M	Common Stock, $0.10 par value	1,235	$0.00	$0	6,301
2025-08-02	Short Bartie Wendy	EVP, Corporate Affairs	Exercise / conversion M · derivative	Restricted Stock Units	738	$0.00	$0	0
2025-08-02	Short Bartie Wendy	EVP, Corporate Affairs	Open-market sell S	Common Stock, $0.10 par value	378	$44.23	$16,719	5,066
2025-08-02	Short Bartie Wendy	EVP, Corporate Affairs	Exercise / conversion M	Common Stock, $0.10 par value	738	$0.00	$0	5,444
2025-08-01	Massacesi Cristian	EVP,Chief Med Offr,Head of Dev	Equity grant / award A · derivative	Restricted Stock Units	204,691	$0.00	$0	204,691
2025-07-01	Shibutani Hiroshi Chris	EVP, Chief Strategy Officer	Equity grant / award A · derivative	Restricted Stock Units	12,810	$0.00	$0	12,810
2025-06-30	Arduini Peter J	Dir	Equity grant / award A · derivative	Deferred Share Units	729	$0.00	$0	62,989
2025-06-13	BOERNER CHRISTOPHER S.	Chief Executive Officer	Equity grant / award G	Common Stock, $0.10 par value	62,719	$0.00	$0	125,439
2025-06-03	Short Bartie Wendy	EVP, Corporate Affairs	Exercise / conversion M · derivative	Restricted Stock Units	8,040	$0.00	$0	16,080
2025-06-03	Short Bartie Wendy	EVP, Corporate Affairs	Other disposed transaction F	Common Stock, $0.10 par value	3,334	$48.09	$160,332	4,706
2025-06-03	Short Bartie Wendy	EVP, Corporate Affairs	Exercise / conversion M	Common Stock, $0.10 par value	8,040	$0.00	$0	8,040
2025-05-09	Hickey Benjamin	President, RayzeBio Org.	Open-market sell S	Common Stock, $0.10 par value	97	$38.01	$3,702	0
2025-05-01	Lenkowsky Adam	EVP, Chief Commercial Officer	Other disposed transaction J · derivative	Market Share Units	1,373	$0.00	$0	2,748
2025-04-25	Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	Open-market buy P	Common Stock, $0.10 par value	4,250	$47.58	$202,215	83,513
2025-04-01	Shanahan Karin	EVP, Glob. Prod. Dev. & Supply	Exercise / conversion M · derivative	Restricted Stock Units	3,306	$0.00	$0	3,307
2025-04-01	Shanahan Karin	EVP, Glob. Prod. Dev. & Supply	Other disposed transaction F	Common Stock, $0.10 par value	1,692	$59.55	$100,759	13,797
2025-04-01	Shanahan Karin	EVP, Glob. Prod. Dev. & Supply	Exercise / conversion M	Common Stock, $0.10 par value	3,306	$0.00	$0	15,489
2025-03-31	YALE PHYLLIS R	Dir	Equity grant / award A · derivative	Deferred Share Units	574	$60.99	$35,000	35,251
2025-03-10	Plenge Robert M	EVP, Chief Research Officer	Equity grant / award A · derivative	Performance Shares	35,146	$0.00	$0	35,146
2025-03-10	Plenge Robert M	EVP, Chief Research Officer	Exercise / conversion M · derivative	Performance Shares	6,641	$0.00	$0	0
2025-03-10	Plenge Robert M	EVP, Chief Research Officer	Equity grant / award A · derivative	Market Share Units	23,431	$0.00	$0	23,431
2025-03-10	Plenge Robert M	EVP, Chief Research Officer	Exercise / conversion M · derivative	Market Share Units	2,342	$0.00	$0	4,684
2025-03-10	Plenge Robert M	EVP, Chief Research Officer	Exercise / conversion M · derivative	Market Share Units	1,107	$0.00	$0	1,107
2025-03-10	Plenge Robert M	EVP, Chief Research Officer	Exercise / conversion M · derivative	Market Share Units	1,165	$0.00	$0	0
2025-03-10	Plenge Robert M	EVP, Chief Research Officer	Other disposed transaction F	Common Stock, $0.10 par value	1,860	$63.11	$117,385	15,839
2025-03-10	Plenge Robert M	EVP, Chief Research Officer	Other disposed transaction J	Common Stock, $0.10 par value	2,449	$0.00	$0	17,699
2025-03-10	Plenge Robert M	EVP, Chief Research Officer	Exercise / conversion M	Common Stock, $0.10 par value	6,641	$0.00	$0	20,148
2025-03-10	Plenge Robert M	EVP, Chief Research Officer	Other disposed transaction F	Common Stock, $0.10 par value	862	$63.11	$54,401	13,507
2025-03-10	Plenge Robert M	EVP, Chief Research Officer	Other disposed transaction J	Common Stock, $0.10 par value	399	$0.00	$0	14,369
2025-03-10	Plenge Robert M	EVP, Chief Research Officer	Exercise / conversion M	Common Stock, $0.10 par value	2,342	$0.00	$0	14,768
2025-03-10	Plenge Robert M	EVP, Chief Research Officer	Other disposed transaction F	Common Stock, $0.10 par value	406	$63.11	$25,623	12,426
2025-03-10	Plenge Robert M	EVP, Chief Research Officer	Other disposed transaction J	Common Stock, $0.10 par value	193	$0.00	$0	12,832
2025-03-10	Plenge Robert M	EVP, Chief Research Officer	Exercise / conversion M	Common Stock, $0.10 par value	1,107	$0.00	$0	13,025
2025-03-10	Plenge Robert M	EVP, Chief Research Officer	Other disposed transaction F	Common Stock, $0.10 par value	482	$63.11	$30,419	11,918
2025-03-10	Plenge Robert M	EVP, Chief Research Officer	Other disposed transaction J	Common Stock, $0.10 par value	80	$0.00	$0	12,400
2025-03-10	Plenge Robert M	EVP, Chief Research Officer	Exercise / conversion M	Common Stock, $0.10 par value	1,165	$0.00	$0	12,480
2025-03-01	Hickey Benjamin	President, RayzeBio Org.	Exercise / conversion M · derivative	Restricted Stock Units	3,286	$0.00	$0	6,572
2025-03-01	Hickey Benjamin	President, RayzeBio Org.	Other disposed transaction F	Common Stock, $0.10 par value	1,630	$59.62	$97,181	8,789
2025-03-01	Hickey Benjamin	President, RayzeBio Org.	Exercise / conversion M	Common Stock, $0.10 par value	3,286	$0.00	$0	10,419
2025-02-20	BOERNER CHRISTOPHER S.	Chief Executive Officer	Open-market buy P	Common Stock, $0.10 par value	2,000	$55.05	$110,096	104,626
2025-02-14	Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	Open-market buy P	Common Stock, $0.10 par value	1,823	$54.84	$100,000	63,932
2025-02-01	YALE PHYLLIS R	Dir	Equity grant / award A · derivative	Deferred Share Units	3,562	$58.95	$210,000	34,677
2024-12-31	YALE PHYLLIS R	Dir	Equity grant / award A · derivative	Deferred Share Units	619	$56.56	$35,000	30,796
2024-11-04	Holzer Phil M	SVP and Controller	Open-market sell S	Common Stock, $0.10 par value	700	$55.62	$38,930	11,760
2024-11-01	Shanahan Karin	EVP, Glob. Prod. Dev. & Supply	Equity grant / award A · derivative	Restricted Stock Units	18,843	$0.00	$0	18,843
2024-10-02	Gallman Cari	EVP, Corporate Affairs	Exercise / conversion M · derivative	Restricted Stock Units	4,558	$0.00	$0	9,117
2024-10-02	Gallman Cari	EVP, Corporate Affairs	Other disposed transaction F	Common Stock, $0.10 par value	1,648	$53.76	$88,596	5,019
2024-10-02	Gallman Cari	EVP, Corporate Affairs	Exercise / conversion M	Common Stock, $0.10 par value	4,558	$0.00	$0	6,667
2024-09-30	YALE PHYLLIS R	Dir	Equity grant / award A · derivative	Deferred Share Units	676	$51.74	$35,000	29,848
2024-08-01	Gallman Cari	EVP, Corporate Affairs	Exercise / conversion M · derivative	Restricted Stock Units	1,061	$0.00	$0	2,122
2024-08-01	Gallman Cari	EVP, Corporate Affairs	Other disposed transaction F	Common Stock, $0.10 par value	384	$48.17	$18,497	2,109
2024-08-01	Gallman Cari	EVP, Corporate Affairs	Exercise / conversion M	Common Stock, $0.10 par value	1,061	$0.00	$0	2,493
2024-07-29	McMullen Michael R.	Dir	Other disposed transaction J · derivative	Call Option (obligation to sell)	5	$0.00	$0	0
2024-07-01	McMullen Michael R.	Dir	Equity grant / award A · derivative	Deferred Share Units	2,987	$41.30	$123,361	2,987
2024-06-30	YALE PHYLLIS R	Dir	Equity grant / award A · derivative	Deferred Share Units	843	$41.53	$35,000	28,813
2024-05-01	Lenkowsky Adam	EVP, Chief Commercial Officer	Other disposed transaction J · derivative	Market Share Units	1,373	$0.00	$0	4,121
2024-04-01	Shanahan Karin	EVP, Glob. Prod. Dev. & Supply	Exercise / conversion M · derivative	Restricted Stock Units	3,306	$0.00	$0	6,613
2024-04-01	Shanahan Karin	EVP, Glob. Prod. Dev. & Supply	Other disposed transaction F	Common Stock, $0.10 par value	1,196	$52.99	$63,376	5,336
2024-04-01	Shanahan Karin	EVP, Glob. Prod. Dev. & Supply	Exercise / conversion M	Common Stock, $0.10 par value	3,306	$0.00	$0	6,532
2024-03-31	YALE PHYLLIS R	Dir	Equity grant / award A · derivative	Deferred Share Units	645	$54.23	$35,000	27,595
2024-03-10	Lenkowsky Adam	EVP, Chief Commercial Officer	Equity grant / award A · derivative	Performance Shares	31,347	$0.00	$0	31,347
2024-03-10	Lenkowsky Adam	EVP, Chief Commercial Officer	Exercise / conversion M · derivative	Performance Shares	11,416	$0.00	$0	0
2024-03-10	Lenkowsky Adam	EVP, Chief Commercial Officer	Equity grant / award A · derivative	Market Share Units	20,898	$0.00	$0	20,898
2024-03-10	Lenkowsky Adam	EVP, Chief Commercial Officer	Other disposed transaction J · derivative	Market Share Units	2,000	$0.00	$0	6,001
2024-03-10	Lenkowsky Adam	EVP, Chief Commercial Officer	Other disposed transaction J · derivative	Market Share Units	1,825	$0.00	$0	3,653
2024-03-10	Lenkowsky Adam	EVP, Chief Commercial Officer	Exercise / conversion M · derivative	Market Share Units	1,902	$0.00	$0	1,904
2024-03-10	Lenkowsky Adam	EVP, Chief Commercial Officer	Exercise / conversion M · derivative	Market Share Units	1,698	$0.00	$0	0
2024-03-10	Lenkowsky Adam	EVP, Chief Commercial Officer	Other disposed transaction F	Common Stock, $0.10 par value	3,235	$53.79	$174,011	6,650
2024-03-10	Lenkowsky Adam	EVP, Chief Commercial Officer	Other disposed transaction J	Common Stock, $0.10 par value	3,974	$0.00	$0	9,885
2024-03-10	Lenkowsky Adam	EVP, Chief Commercial Officer	Exercise / conversion M	Common Stock, $0.10 par value	11,416	$0.00	$0	13,859
2024-03-10	Lenkowsky Adam	EVP, Chief Commercial Officer	Other disposed transaction F	Common Stock, $0.10 par value	570	$53.79	$30,660	2,443
2024-03-10	Lenkowsky Adam	EVP, Chief Commercial Officer	Other disposed transaction J	Common Stock, $0.10 par value	328	$0.00	$0	3,013
2024-03-10	Lenkowsky Adam	EVP, Chief Commercial Officer	Exercise / conversion M	Common Stock, $0.10 par value	1,902	$0.00	$0	3,341
2024-03-10	Lenkowsky Adam	EVP, Chief Commercial Officer	Other disposed transaction F	Common Stock, $0.10 par value	518	$53.79	$27,863	1,439
2024-03-10	Lenkowsky Adam	EVP, Chief Commercial Officer	Other disposed transaction J	Common Stock, $0.10 par value	267	$0.00	$0	1,957
2024-03-10	Lenkowsky Adam	EVP, Chief Commercial Officer	Exercise / conversion M	Common Stock, $0.10 par value	1,698	$0.00	$0	2,224
2024-03-01	Hickey Benjamin	President, RayzeBio Org.	Equity grant / award A · derivative	Restricted Stock Units	9,858	$0.00	$0	9,858
2024-02-01	YALE PHYLLIS R	Dir	Equity grant / award A · derivative	Deferred Share Units	4,315	$48.67	$210,000	26,950
2023-12-31	YALE PHYLLIS R	Dir	Equity grant / award A · derivative	Deferred Share Units	658	$51.31	$33,750	22,359
2023-12-05	BOERNER CHRISTOPHER S.	Chief Executive Officer	Open-market buy P	Common Stock, $0.10 par value	2,000	$49.78	$99,560	82,672
2023-12-02	Plenge Robert M	EVP, Chief Research Officer	Exercise / conversion M · derivative	Restricted Stock Units	616	$0.00	$0	0
2023-12-02	Plenge Robert M	EVP, Chief Research Officer	Other disposed transaction F	Common Stock, $0.10 par value	274	$50.10	$13,727	6,926
2023-12-02	Plenge Robert M	EVP, Chief Research Officer	Exercise / conversion M	Common Stock, $0.10 par value	616	$0.00	$0	7,200
2023-11-28	BOERNER CHRISTOPHER S.	Chief Executive Officer	Open-market buy P	Common Stock, $0.10 par value	3,071	$48.86	$150,049	79,384
2023-11-21	LEUNG SANDRA	EVP, General Counsel	Other acquired transaction J	Common Stock, $0.10 par value	9,830	$48.74	$479,163	93,436
2023-11-20	Samuels Theodore R. II	Dir	Open-market buy P	Common Stock, $0.10 par value	8,500	$49.81	$423,385	35,500
2023-11-01	BOERNER CHRISTOPHER S.	Chief Executive Officer	Equity grant / award A · derivative	Performance Shares	17,788	$0.00	$0	17,788
2023-11-01	BOERNER CHRISTOPHER S.	Chief Executive Officer	Equity grant / award A · derivative	Market Share Units	11,858	$0.00	$0	11,858
2023-10-10	Caforio Giovanni	Board Chair and CEO	Equity grant / award G	Common Stock, $0.10 par value	440	$0.00	$0	367,495
2023-10-02	Gallman Cari	EVP, Corporate Affairs	Equity grant / award A · derivative	Restricted Stock Units	13,675	$0.00	$0	13,675
2023-09-30	YALE PHYLLIS R	Dir	Equity grant / award A · derivative	Deferred Share Units	581	$58.04	$33,750	21,463
2023-08-24	Powell Ann	EVP, Chief Human Resources	Open-market sell S	Common Stock, $0.10 par value	17,986	$61.25	$1,101,642	27,868
2023-08-03	Plenge Robert M	EVP, Chief Research Officer	Open-market sell S	Common Stock, $0.10 par value	732	$61.14	$44,754	6,584
2023-07-01	Weese Michelle	EVP, Corporate Affairs	Exercise / conversion M · derivative	Restricted Stock Units	1,885	$0.00	$0	3,770
2023-07-01	Weese Michelle	EVP, Corporate Affairs	Other disposed transaction F	Common Stock, $0.10 par value	682	$63.95	$43,614	3,453
2023-07-01	Weese Michelle	EVP, Corporate Affairs	Exercise / conversion M	Common Stock, $0.10 par value	1,885	$0.00	$0	4,135
2023-06-30	YALE PHYLLIS R	Dir	Equity grant / award A · derivative	Deferred Share Units	528	$63.95	$33,750	20,690
2023-06-03	Lenkowsky Adam	EVP, Chief Commercial Officer	Exercise / conversion M · derivative	Restricted Stock Units	1,077	$0.00	$0	0
2023-06-03	Lenkowsky Adam	EVP, Chief Commercial Officer	Other disposed transaction F	Common Stock, $0.10 par value	551	$65.66	$36,179	526
2023-06-03	Lenkowsky Adam	EVP, Chief Commercial Officer	Exercise / conversion M	Common Stock, $0.10 par value	1,077	$0.00	$0	1,077
2023-05-03	VESSEY RUPERT	EVP & President, Research	Open-market sell S	Common Stock, $0.10 par value	50,385	$67.06	$3,378,818	47,751
2023-05-02	Greenlees Sharon	SVP & Controller	Exercise / conversion M · derivative	Restricted Stock Units	328	$0.00	$0	984
2023-05-02	Greenlees Sharon	SVP & Controller	Exercise / conversion M · derivative	Market Share Units	689	$0.00	$0	2,067
2023-05-02	Greenlees Sharon	SVP & Controller	Other disposed transaction F	Common Stock, $0.10 par value	119	$68.10	$8,104	609
2023-05-02	Greenlees Sharon	SVP & Controller	Exercise / conversion M	Common Stock, $0.10 par value	328	$0.00	$0	728
2023-05-02	Greenlees Sharon	SVP & Controller	Other disposed transaction F	Common Stock, $0.10 par value	227	$68.10	$15,459	400
2023-05-02	Greenlees Sharon	SVP & Controller	Other disposed transaction J	Common Stock, $0.10 par value	62	$0.00	$0	627
2023-05-02	Greenlees Sharon	SVP & Controller	Exercise / conversion M	Common Stock, $0.10 par value	689	$0.00	$0	689
2023-05-01	Lenkowsky Adam	EVP, Chief Commercial Officer	Equity grant / award A · derivative	Performance Shares	8,241	$0.00	$0	8,241
2023-05-01	Lenkowsky Adam	EVP, Chief Commercial Officer	Equity grant / award A · derivative	Market Share Units	5,494	$0.00	$0	5,494
2023-04-01	Mily Elizabeth	EVP, Strategy & BD	Exercise / conversion M · derivative	Restricted Stock Units	2,684	$0.00	$0	2,685
2023-04-01	Mily Elizabeth	EVP, Strategy & BD	Exercise / conversion M · derivative	Market Share Units	3,662	$0.00	$0	3,663
2023-04-01	Mily Elizabeth	EVP, Strategy & BD	Other disposed transaction F	Common Stock, $0.10 par value	1,139	$69.31	$78,944	34,734
2023-04-01	Mily Elizabeth	EVP, Strategy & BD	Exercise / conversion M	Common Stock, $0.10 par value	2,684	$0.00	$0	35,873
2023-04-01	Mily Elizabeth	EVP, Strategy & BD	Other disposed transaction F	Common Stock, $0.10 par value	2,059	$69.31	$142,709	33,189
2023-04-01	Mily Elizabeth	EVP, Strategy & BD	Other acquired transaction J	Common Stock, $0.10 par value	1,190	$0.00	$0	35,248
2023-04-01	Mily Elizabeth	EVP, Strategy & BD	Exercise / conversion M	Common Stock, $0.10 par value	3,662	$0.00	$0	34,058
2023-03-31	Arduini Peter J	Dir	Equity grant / award A · derivative	Deferred Share Units	487	$69.31	$33,750	44,104
2023-03-10	Mily Elizabeth	EVP, Strategy & BD	Equity grant / award A · derivative	Performance Shares	21,956	$0.00	$0	21,956
2023-03-10	Mily Elizabeth	EVP, Strategy & BD	Exercise / conversion M · derivative	Performance Shares	21,973	$0.00	$0	0
2023-03-10	Mily Elizabeth	EVP, Strategy & BD	Equity grant / award A · derivative	Market Share Units	14,637	$0.00	$0	14,637
2023-03-10	Mily Elizabeth	EVP, Strategy & BD	Exercise / conversion M · derivative	Market Share Units	3,658	$0.00	$0	10,976
2023-03-10	Mily Elizabeth	EVP, Strategy & BD	Exercise / conversion M · derivative	Market Share Units	4,005	$0.00	$0	8,012
2023-03-10	Mily Elizabeth	EVP, Strategy & BD	Other disposed transaction F	Common Stock, $0.10 par value	10,460	$65.71	$687,327	30,396
2023-03-10	Mily Elizabeth	EVP, Strategy & BD	Other acquired transaction J	Common Stock, $0.10 par value	2,683	$0.00	$0	40,856
2023-03-10	Mily Elizabeth	EVP, Strategy & BD	Exercise / conversion M	Common Stock, $0.10 par value	21,973	$0.00	$0	38,173
2023-03-10	Mily Elizabeth	EVP, Strategy & BD	Other disposed transaction F	Common Stock, $0.10 par value	1,602	$65.71	$105,267	16,200
2023-03-10	Mily Elizabeth	EVP, Strategy & BD	Other acquired transaction J	Common Stock, $0.10 par value	118	$0.00	$0	17,802
2023-03-10	Mily Elizabeth	EVP, Strategy & BD	Exercise / conversion M	Common Stock, $0.10 par value	3,658	$0.00	$0	17,684
2023-03-10	Mily Elizabeth	EVP, Strategy & BD	Other disposed transaction F	Common Stock, $0.10 par value	1,978	$65.71	$129,974	14,026
2023-03-10	Mily Elizabeth	EVP, Strategy & BD	Other acquired transaction J	Common Stock, $0.10 par value	657	$0.00	$0	16,004
2023-03-10	Mily Elizabeth	EVP, Strategy & BD	Exercise / conversion M	Common Stock, $0.10 par value	4,005	$0.00	$0	15,347
2023-02-06	Caforio Giovanni	Board Chair and CEO	Open-market sell S	Common Stock, $0.10 par value	240,000	$74.65	$17,916,000	236,104
2023-02-01	Arduini Peter J	Dir	Equity grant / award A · derivative	Deferred Share Units	2,808	$71.23	$200,000	43,617
2022-12-31	Haller Julia A	Dir	Equity grant / award A · derivative	Deferred Share Units	469	$71.95	$33,750	16,826
2022-12-02	BOERNER CHRISTOPHER S.	EVP, Chief Commercial Officer	Exercise / conversion M · derivative	Restricted Stock Units	2,637	$0.00	$0	2,638
2022-12-02	BOERNER CHRISTOPHER S.	EVP, Chief Commercial Officer	Other disposed transaction F	Common Stock, $0.10 par value	1,349	$81.13	$109,444	43,254
2022-12-02	BOERNER CHRISTOPHER S.	EVP, Chief Commercial Officer	Exercise / conversion M	Common Stock, $0.10 par value	2,637	$0.00	$0	44,603
2022-11-09	Powell Ann	EVP, Chief Human Resources	Open-market sell S	Common Stock, $0.10 par value	16,250	$80.45	$1,307,312	34,226
2022-11-07	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M · derivative	Option (right to buy)	8,491	$0.00	$0	0
2022-11-07	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M · derivative	Option (right to buy)	21,288	$0.00	$0	0
2022-11-07	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M · derivative	Option (right to buy)	5,843	$0.00	$0	0
2022-11-07	VESSEY RUPERT	EVP, Research & Early Dev.	Open-market sell S	Common Stock, $0.10 par value	45,910	$78.88	$3,621,381	57,079
2022-11-07	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	8,491	$38.41	$326,139	102,989
2022-11-07	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	21,288	$72.42	$1,541,677	77,516
2022-11-07	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	5,843	$70.89	$414,210	56,228
2022-09-30	Rice Derica W	Dir	Equity grant / award A · derivative	Deferred Share Units	510	$71.09	$36,250	12,001
2022-09-20	Caforio Giovanni	Board Chair and CEO	Open-market sell S	Common Stock, $0.10 par value	25,000	$69.71	$1,742,750	476,104
2022-09-15	Caforio Giovanni	Board Chair and CEO	Open-market sell S	Common Stock, $0.10 par value	50,000	$71.84	$3,592,000	501,104
2022-09-14	Powell Ann	EVP, Chief Human Resources	Open-market sell S	Common Stock, $0.10 par value	25,000	$70.75	$1,768,750	50,476
2022-09-13	Elkins David V	EVP, Chief Financial Officer	Exercise / conversion M · derivative	Option (right to buy)	121,214	$0.00	$0	0
2022-09-13	Elkins David V	EVP, Chief Financial Officer	Exercise / conversion M · derivative	Option (right to buy)	2,063	$0.00	$0	0
2022-09-13	Elkins David V	EVP, Chief Financial Officer	Open-market sell S	Common Stock, $0.10 par value	103,951	$71.29	$7,410,667	119,786
2022-09-13	Elkins David V	EVP, Chief Financial Officer	Exercise / conversion M	Common Stock, $0.10 par value	121,214	$48.49	$5,877,667	223,737
2022-09-13	Elkins David V	EVP, Chief Financial Officer	Exercise / conversion M	Common Stock, $0.10 par value	2,063	$48.49	$100,035	102,523
2022-09-13	Elkins David V	EVP, Chief Financial Officer	Open-market sell S	Common Stock, $0.10 par value	30,000	$71.35	$2,140,500	100,460
2022-07-01	Weese Michelle	EVP, Corporate Affairs	Exercise / conversion M · derivative	Restricted Stock Units	1,885	$0.00	$0	5,655
2022-07-01	Weese Michelle	EVP, Corporate Affairs	Other disposed transaction F	Common Stock, $0.10 par value	682	$76.84	$52,405	1,203
2022-07-01	Weese Michelle	EVP, Corporate Affairs	Exercise / conversion M	Common Stock, $0.10 par value	1,885	$0.00	$0	1,885
2022-06-30	YALE PHYLLIS R	Dir	Equity grant / award A · derivative	Deferred Share Units	438	$77.00	$33,750	15,400
2022-06-14	Bhatt Deepak	Dir	Equity grant / award A · derivative	Deferred Share Units	1,737	$72.87	$126,575	1,737
2022-06-13	Caforio Giovanni	Board Chair and CEO	Open-market sell S	Common Stock, $0.10 par value	30,000	$74.04	$2,221,200	551,104
2022-06-06	LEUNG SANDRA	EVP, General Counsel	Open-market sell S	Common Stock, $0.10 par value	65,000	$74.89	$4,867,850	308,627
2022-06-03	Haller Julia A	Dir	Exercise / conversion M · derivative	Restricted Stock Units	2,949	$0.00	$0	0
2022-06-03	Haller Julia A	Dir	Exercise / conversion M	Common Stock, $0.10 par value	2,949	$0.00	$0	13,619
2022-05-02	Greenlees Sharon	SVP & Controller	Equity grant / award A · derivative	Performance Shares	4,134	$0.00	$0	4,134
2022-05-02	Greenlees Sharon	SVP & Controller	Equity grant / award A · derivative	Market Share Units	2,756	$0.00	$0	2,756
2022-05-02	Greenlees Sharon	SVP & Controller	Equity grant / award A · derivative	Restricted Stock Units	1,312	$0.00	$0	1,312
2022-04-01	Mily Elizabeth	EVP, Strategy & BD	Exercise / conversion M · derivative	Restricted Stock Units	2,685	$0.00	$0	5,369
2022-04-01	Mily Elizabeth	EVP, Strategy & BD	Exercise / conversion M · derivative	Market Share Units	3,662	$0.00	$0	7,325
2022-04-01	Mily Elizabeth	EVP, Strategy & BD	Other disposed transaction F	Common Stock, $0.10 par value	1,139	$73.82	$84,081	11,342
2022-04-01	Mily Elizabeth	EVP, Strategy & BD	Exercise / conversion M	Common Stock, $0.10 par value	2,685	$0.00	$0	12,481
2022-04-01	Mily Elizabeth	EVP, Strategy & BD	Other disposed transaction F	Common Stock, $0.10 par value	2,194	$73.82	$161,961	9,796
2022-04-01	Mily Elizabeth	EVP, Strategy & BD	Other acquired transaction J	Common Stock, $0.10 par value	1,508	$0.00	$0	11,990
2022-04-01	Mily Elizabeth	EVP, Strategy & BD	Exercise / conversion M	Common Stock, $0.10 par value	3,662	$0.00	$0	10,482
2022-03-31	Samuels Theodore R. II	Dir	Equity grant / award A · derivative	Deferred Share Units	668	$73.03	$48,750	31,923
2022-03-22	Caforio Giovanni	Board Chair and CEO	Equity grant / award G	Common Stock, $0.10 par value	420	$0.00	$0	581,104
2022-03-21	Caforio Giovanni	Board Chair and CEO	Open-market sell S	Common Stock, $0.10 par value	25,000	$71.52	$1,788,000	581,524
2022-03-16	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M · derivative	Option (right to buy)	8,490	$0.00	$0	8,491
2022-03-16	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M · derivative	Option (right to buy)	5,294	$0.00	$0	0
2022-03-16	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M · derivative	Option (right to buy)	12,233	$0.00	$0	0
2022-03-16	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M · derivative	Option (right to buy)	21,288	$0.00	$0	0
2022-03-16	VESSEY RUPERT	EVP, Research & Early Dev.	Open-market sell S	Common Stock, $0.10 par value	43,228	$69.23	$2,992,674	50,385
2022-03-16	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	8,490	$38.41	$326,101	93,613
2022-03-16	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	12,233	$54.29	$664,130	85,123
2022-03-16	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	5,294	$55.52	$293,923	72,890
2022-03-16	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	21,288	$66.35	$1,412,459	67,596
2022-03-16	VESSEY RUPERT	EVP, Research & Early Dev.	Open-market sell S	Common Stock, $0.10 par value	31,331	$69.27	$2,170,298	46,308
2022-03-14	Santiago Karen Murphy	SVP & Controller	Open-market sell S	Common Stock, $0.10 par value	6,577	$69.19	$455,096	16,704
2022-03-10	Shanahan Karin	EVP, Glob. Prod. Dev. & Supply	Equity grant / award A · derivative	Performance Shares	14,683	$0.00	$0	14,683
2022-03-10	Shanahan Karin	EVP, Glob. Prod. Dev. & Supply	Equity grant / award A · derivative	Market Share Units	9,789	$0.00	$0	9,789
2022-03-01	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M · derivative	Restricted Stock Units	23,350	$0.00	$0	0
2022-03-01	VESSEY RUPERT	EVP, Research & Early Dev.	Other disposed transaction F	Common Stock, $0.10 par value	10,303	$68.63	$707,095	69,284
2022-03-01	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	23,350	$0.00	$0	79,587
2022-02-24	Caforio Giovanni	Board Chair and CEO	Open-market sell S	Common Stock, $0.10 par value	30,000	$67.00	$2,010,000	453,455
2022-02-04	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M · derivative	Restricted Stock Units	3,593	$0.00	$0	0
2022-02-04	VESSEY RUPERT	EVP, Research & Early Dev.	Other disposed transaction F	Common Stock, $0.10 par value	1,312	$64.99	$85,267	56,237
2022-02-04	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	3,593	$0.00	$0	57,549
2022-02-01	Meyers Gregory Scott	EVP, Chief Digital & Tech Off.	Equity grant / award A · derivative	Restricted Stock Units	10,172	$0.00	$0	10,172
2021-12-31	Rice Derica W	Dir	Equity grant / award A · derivative	Deferred Share Units	561	$62.35	$35,000	7,235
2021-12-16	VESSEY RUPERT	EVP, Research & Early Dev.	Open-market sell S	Common Stock, $0.10 par value	13,100	$61.99	$812,069	31,960
2021-12-16	VESSEY RUPERT	EVP, Research & Early Dev.	Open-market sell S	Common Stock, $0.10 par value	6,198	$61.98	$384,183	45,060
2021-12-02	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M · derivative	Restricted Stock Units	8,792	$0.00	$0	17,584
2021-12-02	VESSEY RUPERT	EVP, Research & Early Dev.	Other disposed transaction F	Common Stock, $0.10 par value	4,498	$55.41	$249,234	51,258
2021-12-02	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	8,792	$0.00	$0	55,756
2021-11-24	von Autenried Paul	EVP, Chief Information Officer	Open-market sell S	Common Stock, $0.10 par value	17,353	$56.92	$987,733	63,536
2021-11-23	von Autenried Paul	EVP, Chief Information Officer	Open-market sell S	Common Stock, $0.10 par value	15,418	$57.47	$886,072	80,889
2021-11-22	von Autenried Paul	EVP, Chief Information Officer	Open-market sell S	Common Stock, $0.10 par value	18,363	$57.17	$1,049,813	96,307
2021-09-30	Arduini Peter J	Dir	Equity grant / award A · derivative	Deferred Share Units	549	$0.00	$0	33,648
2021-09-20	Caforio Giovanni	Board Chair and CEO	Open-market sell S	Common Stock, $0.10 par value	25,000	$60.64	$1,516,000	483,980
2021-08-12	Elkins David V	EVP, Chief Financial Officer	Exercise / conversion M · derivative	Option (right to buy)	59,691	$0.00	$0	0
2021-08-12	Elkins David V	EVP, Chief Financial Officer	Exercise / conversion M · derivative	Option (right to buy)	4,129	$0.00	$0	121,214
2021-08-12	Elkins David V	EVP, Chief Financial Officer	Exercise / conversion M · derivative	Option (right to buy)	6,180	$0.00	$0	2,063
2021-08-12	Elkins David V	EVP, Chief Financial Officer	Open-market sell S	Common Stock, $0.10 par value	59,691	$67.00	$3,999,297	80,008
2021-08-12	Elkins David V	EVP, Chief Financial Officer	Exercise / conversion M	Common Stock, $0.10 par value	59,691	$48.49	$2,894,417	139,699
2021-08-12	Elkins David V	EVP, Chief Financial Officer	Exercise / conversion M	Common Stock, $0.10 par value	4,129	$48.49	$200,215	80,008
2021-08-12	Elkins David V	EVP, Chief Financial Officer	Exercise / conversion M	Common Stock, $0.10 par value	6,180	$48.49	$299,668	75,879
2021-08-12	Elkins David V	EVP, Chief Financial Officer	Open-market sell S	Common Stock, $0.10 par value	40,000	$66.88	$2,675,200	69,699
2021-08-03	Powell Ann	EVP, Chief Human Resources	Open-market sell S	Common Stock, $0.10 par value	23,280	$68.57	$1,596,310	47,613
2021-08-02	Caforio Giovanni	Chairman and CEO	Open-market sell S	Common Stock, $0.10 par value	20,000	$68.58	$1,371,600	508,980
2021-08-01	Elkins David V	EVP, Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Units	46,403	$0.00	$0	0
2021-08-01	Elkins David V	EVP, Chief Financial Officer	Other disposed transaction F	Common Stock, $0.10 par value	23,736	$67.87	$1,610,962	109,699
2021-08-01	Elkins David V	EVP, Chief Financial Officer	Exercise / conversion M	Common Stock, $0.10 par value	46,403	$0.00	$0	133,435
2021-07-30	Dubow Adam	SVP,ChiefCompliance&EthicsOff.	Open-market sell S	Common Stock, $0.10 par value	2,466	$67.90	$167,441	13,777
2021-07-01	Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	Exercise / conversion M · derivative	Restricted Stock Units	9,356	$0.00	$0	18,713
2021-07-01	Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	Other disposed transaction F	Common Stock, $0.10 par value	4,786	$66.56	$318,556	11,752
2021-07-01	Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	Exercise / conversion M	Common Stock, $0.10 par value	9,356	$0.00	$0	16,538
2021-06-30	Arduini Peter J	Dir	Equity grant / award A · derivative	Deferred Share Units	507	$0.00	$0	32,862
2021-06-13	BONNEY MICHAEL W	Dir	Exercise / conversion M · derivative	Restricted Stock Units	902	$0.00	$0	0
2021-06-13	BONNEY MICHAEL W	Dir	Exercise / conversion M	Common Stock, $0.10 par value	902	$0.00	$0	12,501
2021-06-03	BONNEY MICHAEL W	Dir	Exercise / conversion M · derivative	Restricted Stock Units	2,949	$0.00	$0	2,949
2021-06-03	BONNEY MICHAEL W	Dir	Exercise / conversion M	Common Stock, $0.10 par value	2,949	$0.00	$0	11,599
2021-06-01	Hidalgo Medina Manuel	Dir	Equity grant / award A · derivative	Deferred Share Units	1,959	$65.10	$127,535	1,959
2021-05-10	Eid Joseph	SVP,Head Glob. Medical Affairs	Open-market sell S	Common Stock, $0.10 par value	1,118	$65.00	$72,670	8,069
2021-05-08	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M · derivative	Restricted Stock Units	17,245	$0.00	$0	0
2021-05-08	VESSEY RUPERT	EVP, Research & Early Dev.	Other disposed transaction F	Common Stock, $0.10 par value	7,994	$64.44	$515,133	54,390
2021-05-08	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	17,245	$0.00	$0	62,384
2021-05-05	Dubow Adam	SVP,ChiefCompliance&EthicsOff.	Open-market sell S	Common Stock, $0.10 par value	3,119	$64.21	$200,271	16,243
2021-04-01	Mily Elizabeth	EVP, Strategy & BD	Exercise / conversion M · derivative	Restricted Stock Units	2,684	$0.00	$0	8,054
2021-04-01	Mily Elizabeth	EVP, Strategy & BD	Exercise / conversion M · derivative	Market Share Units	3,662	$0.00	$0	10,987
2021-04-01	Mily Elizabeth	EVP, Strategy & BD	Other disposed transaction F	Common Stock, $0.10 par value	1,139	$62.93	$71,677	4,241
2021-04-01	Mily Elizabeth	EVP, Strategy & BD	Exercise / conversion M	Common Stock, $0.10 par value	2,684	$0.00	$0	5,380
2021-04-01	Mily Elizabeth	EVP, Strategy & BD	Other disposed transaction F	Common Stock, $0.10 par value	1,813	$62.93	$114,092	2,696
2021-04-01	Mily Elizabeth	EVP, Strategy & BD	Other acquired transaction J	Common Stock, $0.10 par value	847	$0.00	$0	4,509
2021-04-01	Mily Elizabeth	EVP, Strategy & BD	Exercise / conversion M	Common Stock, $0.10 par value	3,662	$0.00	$0	3,662
2021-03-31	Arduini Peter J	Dir	Equity grant / award A · derivative	Deferred Share Units	574	$63.13	$36,250	32,112
2021-03-22	Caforio Giovanni	Chairman and CEO	Open-market sell S	Common Stock, $0.10 par value	25,000	$62.20	$1,555,000	528,980
2021-03-10	Caforio Giovanni	Chairman and CEO	Equity grant / award A · derivative	Performance Shares	142,904	$0.00	$0	142,904
2021-03-10	Caforio Giovanni	Chairman and CEO	Exercise / conversion M · derivative	Performance Shares	112,343	$0.00	$0	0
2021-03-10	Caforio Giovanni	Chairman and CEO	Equity grant / award A · derivative	Market Share Units	95,269	$0.00	$0	95,269
2021-03-10	Caforio Giovanni	Chairman and CEO	Exercise / conversion M · derivative	Market Share Units	23,407	$0.00	$0	70,223
2021-03-10	Caforio Giovanni	Chairman and CEO	Exercise / conversion M · derivative	Market Share Units	24,793	$0.00	$0	49,586
2021-03-10	Caforio Giovanni	Chairman and CEO	Exercise / conversion M · derivative	Market Share Units	18,723	$0.00	$0	18,726
2021-03-10	Caforio Giovanni	Chairman and CEO	Exercise / conversion M · derivative	Market Share Units	21,443	$0.00	$0	0
2021-03-10	Caforio Giovanni	Chairman and CEO	Other disposed transaction F	Common Stock, $0.10 par value	65,081	$60.93	$3,965,385	553,980
2021-03-10	Caforio Giovanni	Chairman and CEO	Other acquired transaction J	Common Stock, $0.10 par value	15,874	$0.00	$0	619,061
2021-03-10	Caforio Giovanni	Chairman and CEO	Exercise / conversion M	Common Stock, $0.10 par value	112,343	$0.00	$0	603,187
2021-03-10	Caforio Giovanni	Chairman and CEO	Other disposed transaction F	Common Stock, $0.10 par value	12,104	$60.93	$737,497	490,844
2021-03-10	Caforio Giovanni	Chairman and CEO	Other acquired transaction J	Common Stock, $0.10 par value	438	$0.00	$0	502,948
2021-03-10	Caforio Giovanni	Chairman and CEO	Exercise / conversion M	Common Stock, $0.10 par value	23,407	$0.00	$0	502,510
2021-03-10	Caforio Giovanni	Chairman and CEO	Other disposed transaction F	Common Stock, $0.10 par value	14,766	$60.93	$899,692	479,103
2021-03-10	Caforio Giovanni	Chairman and CEO	Other acquired transaction J	Common Stock, $0.10 par value	4,297	$0.00	$0	493,869
2021-03-10	Caforio Giovanni	Chairman and CEO	Exercise / conversion M	Common Stock, $0.10 par value	24,793	$0.00	$0	489,572
2021-03-10	Caforio Giovanni	Chairman and CEO	Other disposed transaction F	Common Stock, $0.10 par value	8,674	$60.93	$528,507	464,779
2021-03-10	Caforio Giovanni	Chairman and CEO	Other disposed transaction J	Common Stock, $0.10 par value	1,635	$0.00	$0	473,453
2021-03-10	Caforio Giovanni	Chairman and CEO	Exercise / conversion M	Common Stock, $0.10 par value	18,723	$0.00	$0	475,088
2021-03-10	Caforio Giovanni	Chairman and CEO	Other disposed transaction F	Common Stock, $0.10 par value	11,608	$60.93	$707,275	456,365
2021-03-10	Caforio Giovanni	Chairman and CEO	Other acquired transaction J	Common Stock, $0.10 par value	1,426	$0.00	$0	467,973
2021-03-10	Caforio Giovanni	Chairman and CEO	Exercise / conversion M	Common Stock, $0.10 par value	21,443	$0.00	$0	466,547
2021-03-01	Elkins David V	EVP, Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Units	24,579	$0.00	$0	24,577
2021-03-01	Elkins David V	EVP, Chief Financial Officer	Other disposed transaction F	Common Stock, $0.10 par value	8,573	$61.63	$528,354	83,186
2021-03-01	Elkins David V	EVP, Chief Financial Officer	Exercise / conversion M	Common Stock, $0.10 par value	24,579	$0.00	$0	91,759
2021-02-04	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M · derivative	Restricted Stock Units	3,592	$0.00	$0	3,593
2021-02-04	VESSEY RUPERT	EVP, Research & Early Dev.	Other disposed transaction F	Common Stock, $0.10 par value	1,186	$61.56	$73,010	57,223
2021-02-04	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	3,592	$0.00	$0	58,409
2021-02-01	Price Paula A	Dir	Equity grant / award A · derivative	Deferred Share Units	3,054	$62.21	$190,000	4,535
2020-12-31	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M · derivative	Restricted Stock Units	25,866	$0.00	$0	0
2020-12-31	VESSEY RUPERT	EVP, Research & Early Dev.	Other disposed transaction F	Common Stock, $0.10 par value	13,257	$62.03	$822,332	54,817
2020-12-31	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	25,866	$0.00	$0	68,074
2020-12-02	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M · derivative	Restricted Stock Units	8,792	$0.00	$0	26,376
2020-12-02	VESSEY RUPERT	EVP, Research & Early Dev.	Other disposed transaction F	Common Stock, $0.10 par value	4,506	$62.18	$280,183	42,208
2020-12-02	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	8,792	$0.00	$0	46,714
2020-12-01	Eid Joseph	SVP,Head Glob. Medical Affairs	Exercise / conversion M · derivative	Restricted Stock Units	2,825	$0.00	$0	2,826
2020-12-01	Eid Joseph	SVP,Head Glob. Medical Affairs	Other disposed transaction F	Common Stock, $0.10 par value	968	$62.41	$60,413	4,391
2020-12-01	Eid Joseph	SVP,Head Glob. Medical Affairs	Exercise / conversion M	Common Stock, $0.10 par value	2,825	$0.00	$0	5,359
2020-11-25	von Autenried Paul	EVP, Chief Information Officer	Open-market sell S	Common Stock, $0.10 par value	3	$63.50	$190	126,698
2020-11-24	Dubow Adam	SVP,ChiefCompliance&EthicsOff.	Open-market sell S	Common Stock, $0.10 par value	900	$63.39	$57,051	15,186
2020-11-23	VESSEY RUPERT	EVP, Research & Early Dev.	Open-market sell S	Common Stock, $0.10 par value	13,421	$61.34	$823,244	37,922
2020-11-19	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M · derivative	Option (right to buy)	8,487	$0.00	$0	16,981
2020-11-19	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M · derivative	Option (right to buy)	8,489	$0.00	$0	16,980
2020-11-19	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M · derivative	Option (right to buy)	12,233	$0.00	$0	12,233
2020-11-19	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M · derivative	Option (right to buy)	14,515	$0.00	$0	0
2020-11-19	VESSEY RUPERT	EVP, Research & Early Dev.	Open-market sell S	Common Stock, $0.10 par value	47,012	$61.31	$2,882,306	51,343
2020-11-19	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	8,487	$38.41	$325,986	98,355
2020-11-19	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	8,489	$47.81	$405,859	89,868
2020-11-19	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	12,233	$54.29	$664,130	72,890
2020-11-19	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	14,515	$54.94	$797,454	60,657
2020-11-19	VESSEY RUPERT	EVP, Research & Early Dev.	Open-market sell S	Common Stock, $0.10 par value	10,579	$61.25	$647,964	46,142
2020-10-30	AHMED NADIM	EVP and President, Hematology	Exercise / conversion M · derivative	Restricted Stock Units	4,650	$0.00	$0	0
2020-10-30	AHMED NADIM	EVP and President, Hematology	Other disposed transaction F	Common Stock, $0.10 par value	2,291	$58.45	$133,909	28,389
2020-10-30	AHMED NADIM	EVP and President, Hematology	Exercise / conversion M	Common Stock, $0.10 par value	4,650	$0.00	$0	30,680
2020-09-30	Vousden Karen H	Dir	Equity grant / award A · derivative	Deferred Share Units	161	$60.29	$9,688	14,345
2020-09-04	Rice Derica W	Dir	Open-market sell S · derivative	Call Option (obligation to sell)	12	$72.50	$870	0
2020-09-01	Price Paula A	Dir	Equity grant / award A · derivative	Deferred Share Units	1,306	$60.97	$79,644	1,306
2020-08-31	Caforio Giovanni	Chairman and CEO	Open-market sell S	Common Stock, $0.10 par value	39,840	$62.70	$2,497,968	445,584
2020-08-17	Eid Joseph	SVP,Head Glob. Medical Affairs	Open-market sell S	Common Stock, $0.10 par value	5,327	$64.00	$340,928	2,534
2020-08-13	LEUNG SANDRA	EVP, General Counsel	Open-market sell S	Common Stock, $0.10 par value	141,420	$63.24	$8,943,401	432,744
2020-08-01	Elkins David V	EVP, Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Units	46,402	$0.00	$0	46,403
2020-08-01	Elkins David V	EVP, Chief Financial Officer	Other disposed transaction F	Common Stock, $0.10 par value	25,916	$58.66	$1,520,233	54,782
2020-08-01	Elkins David V	EVP, Chief Financial Officer	Exercise / conversion M	Common Stock, $0.10 par value	46,402	$0.00	$0	80,698
2020-07-09	CELGENE CORP /DE/	10%	Exercise / conversion X · derivative	Option Warrant	38,979	$0.00	$0	0
2020-07-09	CELGENE CORP /DE/	10%	Open-market sell S	Common Stock	2,241	$102.28	$229,209	7,008,510
2020-07-09	CELGENE CORP /DE/	10%	Exercise / conversion X	Common Stock	38,979	$5.88	$229,197	7,010,751
2020-07-01	CELGENE CORP /DE/	10%	Open-market buy P	Common Stock	108,108	$92.50	$9,999,990	6,971,772
2020-06-30	Samuels Theodore R. II	Dir	Equity grant / award A · derivative	Deferred Share Units	553	$58.80	$32,500	20,049
2020-06-15	Paliwal Dinesh C	Dir	Open-market buy P	Common Stock, $0.10 par value	9,174	$54.50	$499,983	22,109
2020-06-14	BONNEY MICHAEL W	Dir	Exercise / conversion M · derivative	Restricted Stock Units	558	$0.00	$0	0
2020-06-14	BONNEY MICHAEL W	Dir	Exercise / conversion M	Common Stock, $0.10 par value	558	$0.00	$0	8,650
2020-06-13	BONNEY MICHAEL W	Dir	Exercise / conversion M · derivative	Restricted Stock Units	903	$0.00	$0	902
2020-06-13	BONNEY MICHAEL W	Dir	Exercise / conversion M	Common Stock, $0.10 par value	903	$0.00	$0	8,092
2020-06-03	Eid Joseph	SVP,Head Glob. Medical Affairs	Exercise / conversion M · derivative	Restricted Stock Units	2,154	$0.00	$0	6,463
2020-06-03	Eid Joseph	SVP,Head Glob. Medical Affairs	Other disposed transaction F	Common Stock, $0.10 par value	738	$60.21	$44,435	7,861
2020-06-03	Eid Joseph	SVP,Head Glob. Medical Affairs	Exercise / conversion M	Common Stock, $0.10 par value	2,154	$0.00	$0	8,599
2020-05-22	Dubow Adam	SVP,ChiefCompliance&EthicsOff.	Open-market sell S	Common Stock, $0.10 par value	3,200	$61.01	$195,232	16,086
2020-05-19	Schmukler Louis S	EVP,Pres.,Glob.Prod. & Supply	Open-market sell S	Common Stock, $0.10 par value	25,000	$62.68	$1,567,000	26,777
2020-05-01	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M · derivative	Restricted Stock Units	10,707	$0.00	$0	0
2020-05-01	VESSEY RUPERT	EVP, Research & Early Dev.	Other disposed transaction F	Common Stock, $0.10 par value	5,274	$60.26	$317,811	53,776
2020-05-01	VESSEY RUPERT	EVP, Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	10,707	$0.00	$0	59,050
2020-04-01	Mily Elizabeth	EVP, Strategy & BD	Equity grant / award A · derivative	Restricted Stock Units	10,738	$0.00	$0	10,738
2020-04-01	Mily Elizabeth	EVP, Strategy & BD	Equity grant / award A · derivative	Performance Shares	21,973	$0.00	$0	21,973
2020-04-01	Mily Elizabeth	EVP, Strategy & BD	Equity grant / award A · derivative	Market Share Units	14,649	$0.00	$0	14,649
2020-03-31	YALE PHYLLIS R	Dir	Equity grant / award A · derivative	Deferred Share Units	516	$55.74	$28,750	4,369
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Equity grant / award A · derivative	Performance Shares	13,900	$0.00	$0	13,900
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Exercise / conversion M · derivative	Performance Shares	12,321	$0.00	$0	0
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Equity grant / award A · derivative	Market Share Units	9,267	$0.00	$0	9,267
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Exercise / conversion M · derivative	Market Share Units	2,512	$0.00	$0	7,538
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Exercise / conversion M · derivative	Market Share Units	1,917	$0.00	$0	3,834
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Exercise / conversion M · derivative	Market Share Units	2,053	$0.00	$0	2,055
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Exercise / conversion M · derivative	Market Share Units	2,003	$0.00	$0	0
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Other disposed transaction F	Common Stock, $0.10 par value	6,935	$57.93	$401,745	146,701
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Other acquired transaction J	Common Stock, $0.10 par value	1,236	$0.00	$0	153,636
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Exercise / conversion M	Common Stock, $0.10 par value	12,321	$0.00	$0	152,400
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Other disposed transaction F	Common Stock, $0.10 par value	1,573	$57.93	$91,124	140,079
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Other acquired transaction J	Common Stock, $0.10 par value	563	$0.00	$0	141,652
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Exercise / conversion M	Common Stock, $0.10 par value	2,512	$0.00	$0	141,089
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Other disposed transaction F	Common Stock, $0.10 par value	691	$57.93	$40,030	138,577
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Other disposed transaction J	Common Stock, $0.10 par value	92	$0.00	$0	139,268
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Exercise / conversion M	Common Stock, $0.10 par value	1,917	$0.00	$0	139,360
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Other disposed transaction F	Common Stock, $0.10 par value	826	$57.93	$47,850	137,443
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Other acquired transaction J	Common Stock, $0.10 par value	231	$0.00	$0	138,269
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Exercise / conversion M	Common Stock, $0.10 par value	2,053	$0.00	$0	138,038
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Other disposed transaction F	Common Stock, $0.10 par value	713	$57.93	$41,304	135,985
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Other disposed transaction J	Common Stock, $0.10 par value	32	$0.00	$0	136,698
2020-03-10	von Autenried Paul	EVP, Chief Information Officer	Exercise / conversion M	Common Stock, $0.10 par value	2,003	$0.00	$0	136,730
2020-03-04	Elicker John E	EVP, Investor Relations	Open-market sell S	Common Stock, $0.10 par value	15,805	$61.01	$964,263	58,666
2020-03-02	VESSEY RUPERT	Pres., Research & Early Dev.	Exercise / conversion M · derivative	Option (right to buy)	8,489	$0.00	$0	25,468
2020-03-02	VESSEY RUPERT	Pres., Research & Early Dev.	Exercise / conversion M · derivative	Option (right to buy)	24,466	$0.00	$0	24,466
2020-03-02	VESSEY RUPERT	Pres., Research & Early Dev.	Exercise / conversion M · derivative	Option (right to buy)	43,535	$0.00	$0	14,515
2020-03-02	VESSEY RUPERT	Pres., Research & Early Dev.	Open-market sell S	Common Stock, $0.10 par value	84,308	$60.59	$5,108,222	48,343
2020-03-02	VESSEY RUPERT	Pres., Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	8,489	$38.41	$326,062	132,651
2020-03-02	VESSEY RUPERT	Pres., Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	24,466	$54.29	$1,328,259	107,184
2020-03-02	VESSEY RUPERT	Pres., Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	43,535	$54.94	$2,391,813	82,718
2020-03-01	VESSEY RUPERT	Pres., Research & Early Dev.	Exercise / conversion M · derivative	Restricted Stock Units	23,349	$0.00	$0	46,699
2020-03-01	VESSEY RUPERT	Pres., Research & Early Dev.	Other disposed transaction F	Common Stock, $0.10 par value	8,923	$59.06	$526,992	39,183
2020-03-01	VESSEY RUPERT	Pres., Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	23,349	$0.00	$0	48,106
2020-02-04	VESSEY RUPERT	Pres., Research & Early Dev.	Exercise / conversion M · derivative	Restricted Stock Units	3,592	$0.00	$0	7,185
2020-02-04	VESSEY RUPERT	Pres., Research & Early Dev.	Other disposed transaction F	Common Stock, $0.10 par value	1,163	$64.29	$74,769	24,757
2020-02-04	VESSEY RUPERT	Pres., Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	3,592	$0.00	$0	25,920
2020-02-03	Metcalfe Kathryn	EVP, Corporate Affairs	Equity grant / award A · derivative	Restricted Stock Units	13,870	$0.00	$0	13,870
2020-02-01	YALE PHYLLIS R	Dir	Equity grant / award A · derivative	Deferred Share Units	3,018	$62.95	$190,000	3,853
2019-12-31	VESSEY RUPERT	Pres., Research & Early Dev.	Exercise / conversion M · derivative	Restricted Stock Units	16,060	$0.00	$0	0
2019-12-31	VESSEY RUPERT	Pres., Research & Early Dev.	Other disposed transaction F	Common Stock, $0.10 par value	7,910	$64.19	$507,743	22,868
2019-12-31	VESSEY RUPERT	Pres., Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	16,060	$0.00	$0	30,778
2019-12-31	VESSEY RUPERT	Pres., Research & Early Dev.	Other disposed transaction F	Common Stock, $0.10 par value	7,910	$64.19	$507,743	22,328
2019-12-31	VESSEY RUPERT	Pres., Research & Early Dev.	Exercise / conversion M	Common Stock, $0.10 par value	16,060	$0.00	$0	30,238
2019-12-05	Dubow Adam	Chief Compliance & Ethics Offi	Open-market sell S	Common Stock, $0.10 par value	1,740	$58.81	$102,329	15,749
2019-12-04	BONNEY MICHAEL W	Dir	Open-market buy P	Common Stock, $0.10 par value	88	$58.90	$5,183	7,189
2019-12-02	VESSEY RUPERT	Pres., Research & Early Dev.	Equity grant / award A · derivative	Restricted Stock Units	35,168	$0.00	$0	35,168
2019-12-01	Eid Joseph	SVPHead Global Medical Affairs	Exercise / conversion M · derivative	Restricted Stock Units	2,825	$0.00	$0	5,651
2019-12-01	Eid Joseph	SVPHead Global Medical Affairs	Other disposed transaction F	Common Stock, $0.10 par value	968	$56.94	$55,118	4,027
2019-12-01	Eid Joseph	SVPHead Global Medical Affairs	Exercise / conversion M	Common Stock, $0.10 par value	2,825	$0.00	$0	4,995
2019-12-01	Eid Joseph	SVP,Head Glob. Medical Affairs	Exercise / conversion M · derivative	Restricted Stock Units	2,825	$0.00	$0	5,651
2019-12-01	Eid Joseph	SVP,Head Glob. Medical Affairs	Other disposed transaction F	Common Stock, $0.10 par value	968	$56.94	$55,118	5,327
2019-12-01	Eid Joseph	SVP,Head Glob. Medical Affairs	Exercise / conversion M	Common Stock, $0.10 par value	2,825	$0.00	$0	6,295
2019-11-20	Elkins David V	EVP, Chief Financial Officer	Equity grant / award A · derivative	Restricted Stock Units	47,400	$0.00	$0	47,400
2019-11-20	Elkins David V	EVP, Chief Financial Officer	Equity grant / award A · derivative	Restricted Stock Units	73,735	$0.00	$0	73,735
2019-11-20	Elkins David V	EVP, Chief Financial Officer	Equity grant / award A · derivative	Restricted Stock Units	32,995	$0.00	$0	32,995
2019-11-20	Elkins David V	EVP, Chief Financial Officer	Equity grant / award A · derivative	Restricted Stock Units	92,805	$0.00	$0	92,805
2019-11-20	Elkins David V	EVP, Chief Financial Officer	Equity grant / award A · derivative	Option (right to buy)	193,277	$0.00	$0	193,277
2019-11-20	Elkins David V	EVP, Chief Financial Officer	Equity grant / award A	Common Stock, $0.10 par value	195	$0.00	$0	195
2019-11-20	Elkins David V	EVP, Chief Financial Officer	Equity grant / award A	Common Stock, $0.10 par value	13,908	$0.00	$0	13,908
2019-11-20	VESSEY RUPERT	Pres., Research & Early Dev.	Equity grant / award A · derivative	Restricted Stock Units	45,029	$0.00	$0	45,029
2019-11-20	VESSEY RUPERT	Pres., Research & Early Dev.	Equity grant / award A · derivative	Restricted Stock Units	25,866	$0.00	$0	25,866
2019-11-20	VESSEY RUPERT	Pres., Research & Early Dev.	Equity grant / award A · derivative	Restricted Stock Units	16,060	$0.00	$0	16,060
2019-11-05	Schmukler Louis S	Pres., Global Mfg. & Supply	Open-market sell S	Common Stock, $0.10 par value	25,000	$56.56	$1,414,000	31,963
2019-10-02	Biondi Paul	SVP, Head of Strategy & BD	Exercise / conversion M · derivative	Restricted Stock Units	592	$0.00	$0	1,184
2019-10-02	Biondi Paul	SVP, Head of Strategy & BD	Other disposed transaction F	Common Stock, $0.10 par value	203	$49.21	$9,990	6,214
2019-10-02	Biondi Paul	SVP, Head of Strategy & BD	Exercise / conversion M	Common Stock, $0.10 par value	592	$0.00	$0	6,417
2019-09-30	Vousden Karen H	Dir	Equity grant / award A · derivative	Deferred Share Units	764	$50.71	$38,750	9,868
2019-09-01	Santiago Karen Murphy	Controller	Exercise / conversion M · derivative	Restricted Stock Units	641	$0.00	$0	642
2019-09-01	Santiago Karen Murphy	Controller	Other disposed transaction F	Common Stock, $0.10 par value	220	$48.07	$10,575	3,487
2019-09-01	Santiago Karen Murphy	Controller	Exercise / conversion M	Common Stock, $0.10 par value	641	$0.00	$0	3,707
2019-07-31	BERTOLINI ROBERT J	Dir	Open-market buy P	Common Stock, $0.10 par value	11,000	$44.72	$491,920	11,397
2019-07-01	Santiago Karen Murphy	Controller	Equity grant / award A · derivative	Restricted Stock Units	4,277	$0.00	$0	4,277
2019-06-30	Vousden Karen H	Dir	Equity grant / award A · derivative	Deferred Share Units	770	$45.35	$34,918	9,022
2019-06-10	Powell Ann	SVP, Global Human Resources	Other disposed transaction J	Common Stock, $0.10 par value	41,546	$0.00	$0	31,826
2019-05-16	Santiago Karen Murphy	Controller	Open-market sell S	Common Stock, $0.10 par value	3,065	$47.56	$145,771	3,066
2019-05-05	Caforio Giovanni	Chairman and CEO	Exercise / conversion M · derivative	Market Share Units	8,040	$0.00	$0	0
2019-05-05	Caforio Giovanni	Chairman and CEO	Other disposed transaction F	Common Stock, $0.10 par value	2,774	$48.62	$134,872	368,066
2019-05-05	Caforio Giovanni	Chairman and CEO	Other disposed transaction J	Common Stock, $0.10 par value	2,399	$0.00	$0	370,840
2019-05-05	Caforio Giovanni	Chairman and CEO	Exercise / conversion M	Common Stock, $0.10 par value	8,040	$0.00	$0	373,239
2019-04-03	Lynch Thomas J. Jr.	EVP & Chief Scientific Officer	Exercise / conversion M · derivative	Market Share Units	5,298	$0.00	$0	12,143
2019-04-03	Lynch Thomas J. Jr.	EVP & Chief Scientific Officer	Exercise / conversion M · derivative	Restricted Stock Units	6,296	$0.00	$0	12,592
2019-04-03	Lynch Thomas J. Jr.	EVP & Chief Scientific Officer	Other disposed transaction F	Common Stock, $0.10 par value	2,820	$46.88	$132,202	22,223
2019-04-03	Lynch Thomas J. Jr.	EVP & Chief Scientific Officer	Other disposed transaction J	Common Stock, $0.10 par value	773	$0.00	$0	25,043
2019-04-03	Lynch Thomas J. Jr.	EVP & Chief Scientific Officer	Exercise / conversion M	Common Stock, $0.10 par value	5,298	$0.00	$0	25,816
2019-04-03	Lynch Thomas J. Jr.	EVP & Chief Scientific Officer	Other disposed transaction F	Common Stock, $0.10 par value	3,351	$46.88	$157,095	20,518
2019-04-03	Lynch Thomas J. Jr.	EVP & Chief Scientific Officer	Exercise / conversion M	Common Stock, $0.10 par value	6,296	$0.00	$0	23,869
2019-03-31	Vousden Karen H	Dir	Equity grant / award A · derivative	Deferred Share Units	655	$47.71	$31,250	8,180
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Equity grant / award A · derivative	Performance Shares	12,967	$0.00	$0	12,967
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Exercise / conversion M · derivative	Performance Shares	8,001	$0.00	$0	0
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Equity grant / award A · derivative	Market Share Units	8,645	$0.00	$0	8,645
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Exercise / conversion M · derivative	Market Share Units	1,666	$0.00	$0	4,998
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Exercise / conversion M · derivative	Market Share Units	1,890	$0.00	$0	3,781
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Exercise / conversion M · derivative	Market Share Units	1,346	$0.00	$0	1,349
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Exercise / conversion M · derivative	Market Share Units	1,277	$0.00	$0	0
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Other disposed transaction F	Common Stock, $0.10 par value	3,155	$51.39	$162,135	89,471
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Exercise / conversion M	Common Stock, $0.10 par value	8,001	$0.00	$0	92,626
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Other disposed transaction F	Common Stock, $0.10 par value	349	$51.39	$17,935	84,625
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Other disposed transaction J	Common Stock, $0.10 par value	394	$0.00	$0	84,974
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Exercise / conversion M	Common Stock, $0.10 par value	1,666	$0.00	$0	85,368
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Other disposed transaction F	Common Stock, $0.10 par value	463	$51.39	$23,794	83,702
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Other disposed transaction J	Common Stock, $0.10 par value	204	$0.00	$0	84,165
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Exercise / conversion M	Common Stock, $0.10 par value	1,890	$0.00	$0	84,369
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Other disposed transaction F	Common Stock, $0.10 par value	292	$51.39	$15,006	82,479
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Other disposed transaction J	Common Stock, $0.10 par value	284	$0.00	$0	82,771
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Exercise / conversion M	Common Stock, $0.10 par value	1,346	$0.00	$0	83,055
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Other disposed transaction F	Common Stock, $0.10 par value	281	$51.39	$14,441	81,709
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Other disposed transaction J	Common Stock, $0.10 par value	255	$0.00	$0	81,990
2019-03-10	Elicker John E	SVP, Public Affairs & IR	Exercise / conversion M	Common Stock, $0.10 par value	1,277	$0.00	$0	82,245
2018-10-02	Biondi Paul	SVP, Head of Strategy & BD	Exercise / conversion M · derivative	Restricted Stock Units	592	$0.00	$0	1,776
2018-10-02	Biondi Paul	SVP, Head of Strategy & BD	Other disposed transaction F	Common Stock, $0.10 par value	292	$62.80	$18,338	1,041
2018-10-02	Biondi Paul	SVP, Head of Strategy & BD	Exercise / conversion M	Common Stock, $0.10 par value	592	$0.00	$0	1,333

Regulatory Activity

Last 12 months to 2025-04-29

Insider Filings (Forms 3/4/5) — 12 months

Material Event Filings (8-K) — 12 months

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count